Industrial toxicants and Parkinson’s disease

Por Caudle, W. Michael, Guillot, Thomas S., Lazo, Carlos R., Miller, Gary W.
Publicado em 2012

Treadmill Gait Analysis Does Not Detect Motor Deficits in Animal Models of Parkinson’s Disease or Amyotrophic Lateral Sclerosis

Por Guillot, Thomas S., Asress, Seneshaw A., Richardson, Jason R., Glass, Jonathan D., Miller, Gary W.
Publicado em 2008

Pyrethroid pesticide-induced alterations in dopamine transporter function

Por Elwan, Mohamed A., Richardson, Jason R., Guillot, Thomas S., Caudle, W. Michael, Miller, Gary W.
Publicado no Toxicol Appl Pharmacol (2005)

Synapsins Differentially Control Dopamine and Serotonin Release

Por Kile, Brian M., Guillot, Thomas S., Venton, B. Jill, Wetsel, William C., Augustine, George J., Wightman, R. Mark
Publicado em 2010

Chronically Implanted, Nafion-Coated Ag/AgCl Reference Electrodes for Neurochemical Applications

Por Hashemi, Parastoo, Walsh, Paul L., Guillot, Thomas S., Gras-Najjar, Julie, Takmakov, Pavel, Crews, Fulton T., Wightman, R. Mark
Publicado em 2011

Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity

Por Lohr, Kelly M., Stout, Kristen A., Dunn, Amy R., Wang, Minzheng, Salahpour, Ali, Guillot, Thomas S., Miller, Gary W.
Publicado no ACS Chem Neurosci (2015)

Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis

Por Guillot, Thomas S., Shepherd, Kennie R., Richardson, Jason R., Wang, Min Z., Li, Yingjie, Emson, Piers C., Miller, Gary W.
Publicado em 2008

Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice

Por Stout, Kristen A., Dunn, Amy R., Lohr, Kelly M., Alter, Shawn P., Cliburn, Rachel A., Guillot, Thomas S., Miller, Gary W.
Publicado no ACS Chem Neurosci (2016)

Efficacy of Low-Level Laser Therapy for Body Contouring and Spot Fat Reduction

Por Caruso-Davis, Mary K., Guillot, Thomas S., Podichetty, Vinod K., Mashtalir, Nazar, Dhurandhar, Nikhil V., Dubuisson, Olga, Yu, Ying, Greenway, Frank L.
Publicado no Obes Surg (2011)

PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine

Por Street, Sarah E, Walsh, Paul L, Sowa, Nathaniel A, Taylor-Blake, Bonnie, Guillot, Thomas S, Vihko, Pirkko, Wightman, R Mark, Zylka, Mark J
Publicado em 2011

Optimizing the Temporal Resolution of Fast-Scan Cyclic Voltammetry

Por Kile, Brian M., Walsh, Paul L., McElligott, Zoé A., Bucher, Elizabeth S., Guillot, Thomas S., Salahpour, Ali, Caron, Marc G., Wightman, R. Mark
Publicado em 2012

Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration

Por Alter, Shawn P., Stout, Kristen A., Lohr, Kelly M., Taylor, Tonya N., Shepherd, Kennie R., Wang, Minzheng, Guillot, Thomas S., Miller, Gary W.
Publicado no Exp Neurol (2015)

Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system

Por Hatcher, Jaime M., Richardson, Jason R., Guillot, Thomas S., McCormack, Alison L., Di Monte, Donato A., Jones, Dean P., Pennell, Kurt D., Miller, Gary W.
Publicado em 2007

Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder

Por Richardson, Jason R., Taylor, Michele M., Shalat, Stuart L., Guillot, Thomas S., Caudle, W. Michael, Hossain, Muhammad M., Mathews, Tiffany A., Jones, Sara R., Cory-Slechta, Deborah A., Miller, Gary W.
Publicado no FASEB J (2015)

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Por Lohr, Kelly M., Bernstein, Alison I., Stout, Kristen A., Dunn, Amy R., Lazo, Carlos R., Alter, Shawn P., Wang, Minzheng, Li, Yingjie, Fan, Xueliang, Hess, Ellen J., Yi, Hong, Vecchio, Laura M., Goldstein, David S., Guillot, Thomas S., Salahpour, Ali, Miller, Gary W.
Publicado em 2014